Beijing Leadman Biochemistry (300289.SZ) issued a profit warning, expecting a net loss of 67-77 million yuan for the year.
Lidman (300289.SZ) disclosed its performance forecast for 2024, and the company expects to attribute to the shareholders of the listed company...
Beijing Leadman Biochemistry (300289.SZ) disclosed its performance forecast for 2024, with the company expecting a net loss of RMB 67-77 million attributable to shareholders of the listed company; a net loss of RMB 89-99 million after deducting non-recurring gains and losses.
Related Articles

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


